Literature DB >> 17023177

Common variable immunodeficiency: The power of co-stimulation.

Ulrich Salzer1, Bodo Grimbacher.   

Abstract

Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immune deficiency in adults. CVID is characterized by the sequelae of an antibody deficiency syndrome: an impaired terminal B cell differentiation results in hypogammaglobulinemia and susceptibility to recurrent infections by encapsulated bacteria. The clinical course of CVID is complicated by a plethora of systemic immunopathology, including autoimmunity, lymphoproliferation, malignancy and sarcoid-like granulomas. Phenotypic and functional studies in CVID patients revealed multiple abnormalities within the innate and adaptive immune system. The recent description of monogenic defects in ICOS, TACI and CD19 focussed our interest to an impaired T cell-B cell collaboration within the germinal center and intrinsic B cell defects as possible explanations for the etiology of CVID.

Entities:  

Mesh:

Year:  2006        PMID: 17023177     DOI: 10.1016/j.smim.2006.07.004

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  13 in total

1.  No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy.

Authors:  Philipp O Valko; Ramin Khatami; Christian R Baumann; Claudio L Bassetti
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

2.  CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Authors:  Necil Kutukculer; Elif Azarsiz; Guzide Aksu; Neslihan Edeer Karaca
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

3.  Inflammatory bowel disease-like colitis pathology in a patient with common variable immune deficiency.

Authors:  Nil Comunoglu; Sinem Kara; Nuray Kepil
Journal:  BMJ Case Rep       Date:  2015-02-25

4.  Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study.

Authors:  Karolina Kasztalska; Maciej Ciebiada; Barbara Cebula-Obrzut; Paweł Górski
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

5.  Nodular regenerative hyperplasia in common variable immunodeficiency.

Authors:  Ivan J Fuss; Julia Friend; Zhiqiong Yang; Jian Ping He; Lubna Hooda; James Boyer; Liqiang Xi; Mark Raffeld; David E Kleiner; Theo Heller; Warren Strober
Journal:  J Clin Immunol       Date:  2013-02-19       Impact factor: 8.317

Review 6.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 7.  Genetic defects of apoptosis and primary immunodeficiency.

Authors:  Helen C Su; Michael J Lenardo
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

Review 8.  MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

Review 9.  Fungal infections in primary immunodeficiencies.

Authors:  Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2007-06-06       Impact factor: 3.183

10.  A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.

Authors:  Karina M Melo; Karina I Carvalho; Fernanda R Bruno; Lishomwa C Ndhlovu; Wassim M Ballan; Douglas F Nixon; Esper G Kallas; Beatriz T Costa-Carvalho
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.